Skip to main content
Explore URMC

A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors

Research Question:
Is the drug BMS-813160 safe, tolerable and effective when given alone or in combination with other chemotherapy drugs in patients with metastatic colorectal and pancreatic cancers?

Basic Study Information

This study will evaluate the safety profile, tolerability, and effectiveness of the drug BMS-813160 in patients with metastatic colorectal and pancreatic cancers.

Location: University of Rochester Medical Center
Study Reference #: IGIM18001

Lead Researcher (Principal Investigator)

Lead Researcher:  Marcus Noel

Study Contact Information

Study Coordinator: Nicholas Gerbino
Phone: (585) 273-2605

Additional Study Details

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search